Show simple item record

dc.contributoren-US
dc.creatorO'Dwyer, Clare
dc.creatorCormican, Kathryn
dc.date2017-04-11
dc.date.accessioned2019-05-03T13:22:04Z
dc.date.available2019-05-03T13:22:04Z
dc.identifierhttps://www.jotmi.org/index.php/GT/article/view/2223
dc.identifier10.4067/S0718-27242017000100004
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/87196
dc.descriptionThis study explores new product development in a strict regulatory and historically secretive environment. Adopting a systems perspective and a mixed methods approach in our research, we examine medical device development in Ireland. Findings indicate that the possession of a regulatory strategy expedites the rate of commercialization, so too does the generation of clear product definitions and marketing claims in the earliest developmental phases. Moreover, results suggest that if the regulated industry strengthens its culture for regulation by prioritizing regulation over speed to market, by encouraging cross-functional team collaborations, and by taking a more proactive approach in post-marketing surveillance activities, it has the potential to improve customer satisfaction and enhance product innovation. This study provides unique empirical data enriched by the homogeneity of its sample. It also contributes guidance to practitioners of new product development within a regulatory context.en-US
dc.formatapplication/pdf
dc.languageeng
dc.publisherFacultad de Economía y Negocios, Universidad Alberto Hurtadoen-US
dc.relationhttps://www.jotmi.org/index.php/GT/article/view/2223/1063
dc.rightsCopyright (c) 2017 Journal of Technology Management & Innovationen-US
dc.rightshttp://creativecommons.org/licenses/by/4.0en-US
dc.sourceJournal of Technology Management & Innovation; Vol 12, No 1 (2017); 26-38en-US
dc.sourceJournal of Technology Management & Innovation; Vol 12, No 1 (2017); 26-38es-ES
dc.source0718-2724
dc.subjectnew product development; NPD; medical device development; MDD; innovation; technology innovation management; regulation management; regulatory culture; intended use(s); marketing claims; post- marketing surveillance.en-US
dc.titleRegulation – Do or Die: An Analysis of Factors Critical to New Product Development in a Regulatory Contexten-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeArtículo revisado por paresen-US


This item appears in the following Collection(s)

Show simple item record